These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 36227954)
1. Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma. Chang YL; Cheng YF; Chen HS; Wu SC; Hung WH; Chen HC; Huang CL; Cheng CY; Wang BY PLoS One; 2022; 17(10):e0271338. PubMed ID: 36227954 [TBL] [Abstract][Full Text] [Related]
2. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer. Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951 [TBL] [Abstract][Full Text] [Related]
3. Survival Comparison Among Neoadjuvant Chemoradiotherapy Followed by Esophagectomy, Definitive Chemoradiotherapy, and Esophagectomy Alone for Esophageal Squamous Cell Carcinoma. Chen HS; Lin CH; Wu SC; Wang BY Ann Surg Oncol; 2022 Jun; 29(6):3617-3627. PubMed ID: 34994899 [TBL] [Abstract][Full Text] [Related]
4. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis. Nomura M; Oze I; Kodaira T; Abe T; Komori A; Narita Y; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Andoh M; Tachibana H; Uemura N; Tajika M; Niwa Y; Muto M; Muro K Int J Clin Oncol; 2016 Oct; 21(5):890-898. PubMed ID: 26980212 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China. Zhang G; Zhang C; Sun N; Xue L; Yang Z; Fang L; Zhang Z; Luo Y; Gao S; Xue Q; Mu J; Gao Y; Tan F; He J J Cancer Res Clin Oncol; 2022 Apr; 148(4):943-954. PubMed ID: 34013382 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques. Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166 [TBL] [Abstract][Full Text] [Related]
7. Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis. Wang Q; Lang J; Li T; Peng L; Dai W; Jiang Y; Xie T; Fang Q; Wang Y; Wu L; Cao B; Han Y Radiat Oncol; 2020 May; 15(1):119. PubMed ID: 32448253 [TBL] [Abstract][Full Text] [Related]
8. Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma. Wang BY; Wu SC; Chen HC; Hung WH; Lin CH; Huang CL; Chen HS Br J Surg; 2019 Feb; 106(3):255-262. PubMed ID: 30395362 [TBL] [Abstract][Full Text] [Related]
9. A Propensity-matched Analysis Comparing Survival After Esophagectomy Followed by Adjuvant Chemoradiation to Surgery Alone for Esophageal Squamous Cell Carcinoma. Hwang JY; Chen HS; Hsu PK; Chao YK; Wang BY; Huang CS; Liu CC; Wu SC Ann Surg; 2016 Jul; 264(1):100-6. PubMed ID: 26649580 [TBL] [Abstract][Full Text] [Related]
10. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma. Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309 [TBL] [Abstract][Full Text] [Related]
11. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial? Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824 [TBL] [Abstract][Full Text] [Related]
12. Practice pattern and risk of not receiving planned surgery after neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma. Hong TH; Kim TH; Lee G; Yun J; Jeon YJ; Lee J; Shin S; Park SY; Cho JH; Choi YS; Shim YM; Sun JM; Oh D; Kim HK Eur J Cardiothorac Surg; 2024 Jul; 66(1):. PubMed ID: 38913852 [TBL] [Abstract][Full Text] [Related]
13. Comparing survival between neoadjuvant chemoradiotherapy followed by open or thoracoscopic oesophagectomy in patients with oesophageal squamous cell carcinoma. Chen HS; Lin CH; Wu SC; Wang BY Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35303068 [TBL] [Abstract][Full Text] [Related]
14. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial). Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448 [TBL] [Abstract][Full Text] [Related]
15. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy. Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346 [TBL] [Abstract][Full Text] [Related]
16. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179 [TBL] [Abstract][Full Text] [Related]
17. Impact of the interval between neoadjuvant concurrent chemoradiotherapy and esophagectomy in the modern era: a population-based propensity-score-matched retrospective cohort study in Asia. Kuo YH; Chien YW; Chen PR; Feng CL; Li CC; Chien CR World J Surg Oncol; 2019 Dec; 17(1):222. PubMed ID: 31856840 [TBL] [Abstract][Full Text] [Related]
18. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma. Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582 [TBL] [Abstract][Full Text] [Related]
19. A matched cohort comparison of endoscopic resection, chemoradiation and esophagectomy in the treatment of early-stage esophageal squamous cell carcinoma. Swanson J; Littau M; Tonelli C; Cohn T; Luchette FA; Abdelsattar Z; Baker MS Am J Surg; 2023 Mar; 225(3):508-513. PubMed ID: 36473738 [TBL] [Abstract][Full Text] [Related]
20. Salvage Esophagectomy After Definitive Chemoradiotherapy for Squamous Cell Esophageal Cancer: A Propensity Score Matching Study in a High-Volume Center. Pan J; Liu Z; Yang Y; Li B; Hua R; Guo X; Sun Y; Li C; Li Z World J Surg; 2023 Aug; 47(8):2003-2012. PubMed ID: 37097320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]